The smoking cessation pill varenicline has emerged as an essential tool in the fight against nicotine addiction among young people, particularly in their battle against the rise of vaping.Recent research from Harvard-affiliated Mass General Brigham reveals that this FDA-approved medication significantly enhances the chances of teens and young adults quitting vaping, boasting a success rate three times higher than those relying on behavioral therapy alone.
